Screener
Cogent Biosciences, Inc. COGT Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:21 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205170
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Preferred stock, $0.001 par value; 8,979,420 shares authorized; no shares issued or outstanding | — | — |
| Series A non-voting convertible preferred stock, $0.001 par value; 1,000,000 shares authorized; 39,414 and 67,414 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 29,190 | 53,830 |
| Series B non-voting convertible preferred stock, $0.001 par value; 20,580 shares authorized; 4,516 shares issued and outstanding at March 31, 2026 and December 31, 2025 | 35,563 | 35,563 |
| Common stock, $0.001 par value; 300,000,000 shares authorized; 170,773,803 and 160,980,024 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 171 | 161 |
| Additional paid-in capital | 1,828,956 | 1,734,882 |
| Accumulated other comprehensive income (loss) | (415) | 355 |
| Accumulated deficit | (1,285,772) | (1,188,420) |
| Total stockholders’ equity | 607,693 | 636,371 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Cogent Biosciences, Inc.'s common stock?
- Cogent Biosciences, Inc. (COGT) reported common stock of $171K in Q1 2026.
- How has Cogent Biosciences, Inc.'s common stock changed year-over-year?
- Cogent Biosciences, Inc.'s common stock increased by 50.0% year-over-year, from $114K to $171K.
- What is the long-term trend for Cogent Biosciences, Inc.'s common stock?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s common stock has grown at a 38.1% compound annual growth rate (CAGR), from $32K to $161K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Cogent Biosciences, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude